Delivery Order 75N93023D00018-75N93023F00001

Award Date 6/20/23
Potential Completion Date 6/19/30
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Resourcepath, LLC, a woman-owned small business, was awarded a $3,500 firm fixed price delivery order by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. This delivery order is part of a larger indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle titled "DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM" with a total potential value of $12 million and a...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $27,066.73 cost-plus-fixed-fee delivery order to Technical Resources International, Inc. (doing business as Technical Resources Intl), a minority-owned, woman-owned, Hispanic American-owned small business. The delivery order is part of NIAID's Clinical Research Support Services 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract...
This is a Delivery Order under the $3,500.00 Diagnostic Pre-Clinical Services Program IDIQ contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The prime contractor is Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp that provides biopharmaceutical research, development, manufacturing, and testing services. This Delivery Order supports the development of candidate...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,500 firm fixed price delivery order contract to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation, for the Diagnostic Pre-Clinical Services Program. This contract is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle that provides funding for development processes needed to bring candidate infectious disease diagnostics to market. Dynport has previous experience...
This is a delivery order awarded to Medical Science & Computing, LLC by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The $368,867.43 contract provides professional, scientific, and technical support services to the Division of Intramural Research (DIR) and Laboratory of Infectious Diseases (LID) at NIAID. The work is performed in Germantown, MD and the completion date is July 26, 2024. This...
<p>This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The Madrillon Group Inc, a woman-owned small business. The contract, valued at $105,876.90, is for an assessment of NIAID's Research Resources website. The award does not have a set-aside designation. The period of performance is from September 26, 2014 to April 23, 2016. This task order falls under the NIAID Evaluation Services major program.</p>
This is a delivery order awarded under a $3,500,000 indefinite-delivery, indefinite-quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract is for the Diagnostics Pre-Clinical Services Program and is a firm fixed-price arrangement. The prime contractor is Mriglobal, a 501(c)(3) not-for-profit research organization that provides scientific research, testing, training, and product...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $2,000 firm fixed price delivery order against an unspecified contract vehicle to Lovelace Biomedical Research Institute. The delivery order is for comprehensive and rapid response services to support NIAID's research programs over a one year period from September 2021 through August 2022. The place of performance will be in Bethesda, Maryland. No set aside designation or subcontractors were...
This is a delivery order award to Dynport Vaccine Company LLC (DVC), a subsidiary of General Dynamics Corp, under the $36 million Diagnostic Pre-Clinical Services Program IDIQ contract with the National Institute of Allergy and Infectious Diseases (NIAID). The task order is for a 7-year period of performance with a ceiling value of $3,500. It does not have a set-aside designation. Under this contract, DVC will provide a range of research, development, manufacturing, and testing services to...
Medical Science &amp; Computing, LLC was awarded a $117,158.40 delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Professional, Scientific and Technical Support Services indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health (NIH). The delivery order is to provide professional, scientific, and technical support services for the NIAID Division of Intramural Research/Laboratory of Persistent Viral Diseases (DIR/LPD) in...
  • 75N93023D00018
    Indefinite Delivery Contract
  • 75N93023D00018-75N93023F00001
    Delivery Order

Resourcepath, LLC, a Woman-Owned Small Business, was awarded a $3,500 firm fixed price delivery order by the National Institute of Allergy and Infectious Diseases (NIAID) under the DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM indefinite-delivery/indefinite-quantity (IDIQ) contract. The delivery order is for pre-clinical diagnostic services program support to be performed in Sterling, Virginia through June 2030. The IDIQ contract has a potential value of $12 million and a period of performance through June 2030. The contract's scope includes providing diagnostic pre-clinical services to support the development of in vitro diagnostic products. No set-aside designation or major subcontractors were indicated.

Generated 9/17/24, 9:24 AM